Peroxisome proliferators (PPs) are a class of non-genotoxic chemicals that
cause rodent liver enlargement and hepatocarcinogenesis. In primary rat hep
atocytes, PPs cause cell proliferation, suppression of apoptosis and peroxi
some proliferation. We have investigated the role of different families of
mitogen-activated protein (MAP) kinases in the mode of action of PPs, Addit
ion of 50 mu M nafenopin to primary rat hepatocyte cultures caused weak act
ivation of extracellular signal regulated kinases and p38 MAP kinase. Howev
er, incubation of primary hepatocytes with the p38 MAP kinase inhibitor SB2
03580 or the MAP kinase kinase (MEK) inhibitor PD098059 prevented the induc
tion of DNA synthesis and the suppression of transforming growth factor bet
a(1)-induced apoptosis by the PP nafenopin. In contrast, in the presence of
these MAP kinase inhibitors, nafenopin still induced palmitoyl CoA oxidati
on, a measure of peroxisome proliferation. We have shown previously that PP
s such as nafenopin require tumour necrosis factor alpha (TNF-alpha) to exe
rt their effects on cellular proliferation and apoptosis, Here me show that
treatment of primary rat hepatocyte cultures,vith nafenopin causes an incr
ease in bioactive TNF-alpha and that this process requires p38 MAP kinase a
ctivity.